LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
LeMaitre Vascular (Nasdaq: LMAT) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to deliver their presentation on Tuesday, April 8, 2025, at 3:45 PM EDT. This virtual event represents an opportunity for investors and healthcare industry stakeholders to gain insights into LeMaitre's operations and strategic initiatives.
LeMaitre Vascular (Nasdaq: LMAT) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. Il team di gestione dell'azienda è programmato per presentare il proprio intervento martedì, 8 aprile 2025, alle 15:45 EDT. Questo evento virtuale rappresenta un'opportunità per investitori e attori dell'industria sanitaria di ottenere informazioni sulle operazioni e le iniziative strategiche di LeMaitre.
LeMaitre Vascular (Nasdaq: LMAT) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham. El equipo de gestión de la empresa está programado para presentar su intervención el martes 8 de abril de 2025, a las 3:45 PM EDT. Este evento virtual representa una oportunidad para que inversores y actores de la industria de la salud obtengan información sobre las operaciones e iniciativas estratégicas de LeMaitre.
LeMaitre Vascular (Nasdaq: LMAT)는 제24회 니드햄 가상 의료 회의에 참여할 예정이라고 발표했습니다. 회사의 경영진은 2025년 4월 8일 화요일 오후 3시 45분 EDT에 발표를 진행할 예정입니다. 이 가상 이벤트는 투자자와 의료 산업 관계자들에게 LeMaitre의 운영 및 전략적 이니셔티브에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
LeMaitre Vascular (Nasdaq: LMAT) a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Santé de Needham. L'équipe de direction de l'entreprise doit présenter sa communication le mardi 8 avril 2025, à 15h45 EDT. Cet événement virtuel représente une occasion pour les investisseurs et les acteurs de l'industrie de la santé d'obtenir des informations sur les opérations et les initiatives stratégiques de LeMaitre.
LeMaitre Vascular (Nasdaq: LMAT) hat seine bevorstehende Teilnahme an der 24. jährlichen Needham virtuellen Gesundheitskonferenz angekündigt. Das Management-Team des Unternehmens wird voraussichtlich am Dienstag, den 8. April 2025, um 15:45 Uhr EDT seine Präsentation halten. Diese virtuelle Veranstaltung bietet Investoren und Akteuren der Gesundheitsbranche die Möglichkeit, Einblicke in die Abläufe und strategischen Initiativen von LeMaitre zu gewinnen.
- None.
- None.
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com